File:41416 2020 903 Fig2 HTML.webp
Jump to navigation
Jump to search
Size of this PNG preview of this WEBP file: 541 × 599 pixels. Other resolutions: 217 × 240 pixels | 433 × 480 pixels | 685 × 759 pixels.
Original file (685 × 759 pixels, file size: 41 KB, MIME type: image/webp)
Summary
| Description |
English: Overview of current therapies under investigation for the most common types of tumour associated with NF1, including inhibitors of receptor tyrosine kinases (RTKs) upstream of RAS (capmatinib), components of the pathway downstream of RAS (MEK inhibitors), immune-checkpoint inhibitors (ipilimumab, nivolumab, pembrolizumab) and BET inhibitors. |
| Date | |
| Source | https://www.nature.com/articles/s41416-020-0903-x |
| Author | Jean-Philippe Brosseau, Chung-Ping Liao & Lu Q. Le |
Licensing
This file is licensed under the Creative Commons Attribution 4.0 International license.
- You are free:
- to share – to copy, distribute and transmit the work
- to remix – to adapt the work
- Under the following conditions:
- attribution – You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
|
This media file is uncategorized.
Please help improve this media file by adding it to one or more categories, so it may be associated with related media files (how?), and so that it can be more easily found.
Please notify the uploader with {{subst:Please link images|File:41416 2020 903 Fig2 HTML.webp}} ~~~~ |
File history
Click on a date/time to view the file as it appeared at that time.
| Date/Time | Thumbnail | Dimensions | User | Comment | |
|---|---|---|---|---|---|
| current | 22:17, 2 March 2024 | | 685 × 759 (41 KB) | commons>Ozzie10aaaa | Uploaded a work by Jean-Philippe Brosseau, Chung-Ping Liao & Lu Q. Le from https://www.nature.com/articles/s41416-020-0903-x with UploadWizard |
File usage
There are no pages that use this file.
